Investors | News | Contact Us | Join E-mail List | Careers   

Home | LuViva | Technology | Clinical Trials

 

News Releases

Board of Directors

Audit Committee Charter

Compensation Committee Charter

Key People

Regulatory Filings

Stock Quote

 

All Filings  |  Annual Reports  |  Quarterly Results  |  Proxies  |  Ownership Document
 1     
Filing Date Form Type Description View
May 18, 2012 4 Statement of changes in beneficial ownership of securities  
May 15, 2012 424B3 Prospectus  
May 15, 2012 424B3 Prospectus  
May 15, 2012 4 Statement of changes in beneficial ownership of securities  
May 14, 2012 10-Q Quarterly report    
May 2, 2012 4 Statement of changes in beneficial ownership of securities  
Apr 30, 2012 DEF 14A Other definitive proxy statements  
Apr 24, 2012 4 Statement of changes in beneficial ownership of securities  
Apr 23, 2012 4 Statement of changes in beneficial ownership of securities  
Apr 19, 2012 4 Statement of changes in beneficial ownership of securities  
Apr 19, 2012 8-K Current report  
Apr 19, 2012 424B3 Prospectus  
Apr 19, 2012 424B3 Prospectus  
Apr 19, 2012 3 Initial statement of beneficial ownership of securities  
Apr 18, 2012 4 Statement of changes in beneficial ownership of securities  
Apr 17, 2012 PRE 14A Other preliminary proxy statements  
Apr 2, 2012 POS AM Post-Effective amendments for registration statement    
Apr 2, 2012 4 Statement of changes in beneficial ownership of securities  
Apr 2, 2012 POS AM Post-Effective amendments for registration statement    
Mar 30, 2012 8-K Current report  
 1     

©2011 Guided Therapeutics, Inc.

5835 Peachtree Corners East

Suite D

Norcross, GA 30092

770-242-8723

770-242-8639 - Fax

www.guidedinc.com

info@guidedinc.com

Terms of Service

cervical cancer, cervical cancer vaccine, spectrx, HPV, Pap test, pap smear, Human Papilloma virus, Human Papillomavirus, noninvasive, non-invasive, cancer detection, cancer products